Nations Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,082	Closed	-$1.14M	–	704
2024 Q3	$1.14M	Buy	1,082 +37	+4%	+$41.2K	0.08%	254
2024 Q2	$1.1M	Sell	1,045 -21	-2%	-$20.4K	0.09%	244
2024 Q1	$1.03M	Buy	1,066 +135	+15%	+$128K	0.09%	257
2023 Q4	$818K	Buy	931 +6	+0.6%	+$4.94K	0.08%	275
2023 Q3	$761K	Buy	925 +13	+1%	+$10.2K	0.08%	274
2023 Q2	$655K	Sell	912 -2	-0.2%	-$1.54K	0.06%	319
2023 Q1	$751K	Buy	914 +43	+5%	+$32.4K	0.08%	274
2022 Q4	$628K	Sell	871 -21	-2%	-$15.5K	0.07%	306
2022 Q3	$614K	Sell	892 -64	-7%	-$40.3K	0.09%	246
2022 Q2	$565K	Buy	956 +1	+0.1%	+$650	0.08%	282
2022 Q1	$667K	Buy	955 +70	+8%	+$44.3K	0.08%	269
2021 Q4	$559K	Buy	885 +25	+3%	+$15.4K	0.07%	276
2021 Q3	$521K	Sell	860 -26	-3%	-$16.1K	0.08%	259
2021 Q2	$495K	Buy	886 +32	+4%	+$16.2K	0.08%	258
2021 Q1	$404K	Sell	854 -172	-17%	-$83.7K	0.09%	248
2020 Q4	$496K	Sell	1,026 -12	-1%	-$6.48K	0.13%	198
2020 Q3	$581K	Buy	1,038 +194	+23%	+$118K	0.18%	151
2020 Q2	$526K	Buy	844 +130	+18%	+$73.8K	0.19%	157
2020 Q1	$349K	Buy	+714	New	+$295K	0.15%	171